Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other Non-Current Liabilities (2018 - 2025)

Ocular Therapeutix has reported Other Non-Current Liabilities over the past 10 years, most recently at $887000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $887000.0 for Q4 2025, down 93.3% from a year ago — trailing twelve months through Dec 2025 was $887000.0 (down 93.3% YoY), and the annual figure for FY2025 was $887000.0, down 93.3%.
  • Other Non-Current Liabilities for Q4 2025 was $887000.0 at Ocular Therapeutix, up from $151000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for OCUL hit a ceiling of $73.3 million in Q1 2021 and a floor of $100000.0 in Q1 2023.
  • Median Other Non-Current Liabilities over the past 5 years was $11.8 million (2023), compared with a mean of $15.9 million.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 99.24% in 2023 and later soared 12379.28% in 2025.
  • Ocular Therapeutix's Other Non-Current Liabilities stood at $20.2 million in 2021, then plummeted by 42.58% to $11.6 million in 2022, then tumbled by 99.07% to $108000.0 in 2023, then soared by 12164.81% to $13.2 million in 2024, then tumbled by 93.3% to $887000.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $887000.0 (Q4 2025), $151000.0 (Q3 2025), and $14.0 million (Q2 2025) per Business Quant data.